Provider of therapeutic services designed to offer novel ultrasound device for the treatment of cancer. The company's therapeutic services include development of devices that use phased array technology consisting of transducers, resulting in focused beams that can be steered in three-dimensional imaging, providing consumers with ultrasound surgery devices to treat and melt cancer tumors.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Out of Business | 05-Feb-2019 | 00000 | Completed | Out of Business | ||
1. Early Stage VC | 27-Jan-2012 | 00000 | 00000 | 00.000 | Completed | Startup |
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Ordinary | 000 | 0000 | 0000 | 00 | 0000 | 00.000 |